Administration

Information

• Research Project
• 8380998

• ApplicationId

  8380998

• Core Project Number

  P01HL103526

• Full Project Number

  5P01HL103526-02

• Serial Number

  103526

• FOA Number

  PAR-10-285

• Sub Project Id

  8031

• Project Start Date

  -

• Project End Date

  9/30/2012 - 11 years ago

• Program Officer Name

• Budget Start Date

  7/1/2012 - 12 years ago

• Budget End Date

  6/30/2013 - 11 years ago

• Fiscal Year

  2012

• Support Year

  02

• Suffix

• Award Notice Date

  7/3/2012 - 12 years ago

Organizations

• IMMUNE DISEASE INSTITUTE, INC.

Core A: Administration, Timothy A. Springer Dr. Springer as Program Director assumes responsibility for overseeing the quality ofthe program as a whole and promoting interactions within it. Under the Adminstrative Core, Dr. Springer will ensure that the overall objectives of the program are met, as described in the Program Introduction and Statement of Objectives.

IC Name

• Activity

  P01

• Administering IC

  HL

• Application Type

  5

• Direct Cost Amount

  42958

• Indirect Cost Amount

  45965

• Total Cost

• Sub Project Total Cost

  88923

• ARRA Funded

  False

• CFDA Code

• Ed Inst. Type

• Funding ICs

  NHLBI:88923\

• Funding Mechanism

  Non-SBIR/STTR RPGs

• Study Section

  HLBP

• Study Section Name

  Heart, Lung, and Blood Initial Review Group

• Organization Name

  IMMUNE DISEASE INSTITUTE, INC.

• Organization Department

• Organization DUNS

  059709394

• Organization City

  BOSTON

• Organization State

  MA

• Organization Country

  UNITED STATES

• Organization Zip Code

  021155713

• Organization District

  UNITED STATES